PT874845E - Derivados de pirido¬2,3-b|pirazina - Google Patents
Derivados de pirido¬2,3-b|pirazinaInfo
- Publication number
- PT874845E PT874845E PT96941882T PT96941882T PT874845E PT 874845 E PT874845 E PT 874845E PT 96941882 T PT96941882 T PT 96941882T PT 96941882 T PT96941882 T PT 96941882T PT 874845 E PT874845 E PT 874845E
- Authority
- PT
- Portugal
- Prior art keywords
- alkenyl
- pyridyl
- phenyl
- amino
- alkenoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526558.3A GB9526558D0 (en) | 1995-12-27 | 1995-12-27 | Heterobicyclic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PT874845E true PT874845E (pt) | 2002-08-30 |
Family
ID=10786098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96941882T PT874845E (pt) | 1995-12-27 | 1996-12-13 | Derivados de pirido¬2,3-b|pirazina |
Country Status (18)
Country | Link |
---|---|
US (1) | US6117875A (pt) |
EP (1) | EP0874845B1 (pt) |
JP (1) | JP2000502699A (pt) |
KR (1) | KR19990072053A (pt) |
CN (1) | CN1066732C (pt) |
AT (1) | ATE214067T1 (pt) |
AU (1) | AU720301B2 (pt) |
CA (1) | CA2241690A1 (pt) |
DE (1) | DE69619702T2 (pt) |
DK (1) | DK0874845T3 (pt) |
EA (1) | EA001324B1 (pt) |
ES (1) | ES2170286T3 (pt) |
GB (1) | GB9526558D0 (pt) |
HU (1) | HUP9901038A3 (pt) |
IL (1) | IL124673A (pt) |
MX (1) | MX9805129A (pt) |
PT (1) | PT874845E (pt) |
WO (1) | WO1997024355A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9413975D0 (en) | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
CA2715683A1 (en) | 1999-08-21 | 2001-03-01 | Nycomed Gmbh | Synergistic combination |
KR20020069362A (ko) | 2000-01-20 | 2002-08-30 | 에자이 가부시키가이샤 | 함질소환 화합물 및 이들을 포함하는 의약 조성물 |
DE60143098D1 (de) | 2000-05-31 | 2010-10-28 | Santen Pharmaceutical Co Ltd | (Pyridinyl)alkyl-Amide oder -Harnstoffe als TNF-alpha Bildung Inhibitoren |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
ES2372600T3 (es) * | 2002-11-06 | 2012-01-24 | Aska Pharmaceutical Co., Ltd. | Derivado de pirazolonaftiridina. |
US7504401B2 (en) * | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
EP1729771B1 (en) | 2004-03-22 | 2009-10-14 | Eli Lilly & Company | Pyridyl derivatives and their use as mglu5 receptor antagonists |
WO2006126081A2 (en) * | 2005-05-24 | 2006-11-30 | Pharmacia & Upjohn Company Llc | Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors |
US20080280891A1 (en) * | 2006-06-27 | 2008-11-13 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
BRPI0908569B8 (pt) | 2008-03-05 | 2021-05-25 | Merck Patent Gmbh | estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica |
WO2010096426A2 (en) * | 2009-02-20 | 2010-08-26 | Emory University | Compounds, compositions, methods of synthesis, and methods of treatment |
CN101875627B (zh) * | 2009-04-30 | 2014-01-15 | 凯惠科技发展(上海)有限公司 | 一种1-烷氧羰基-2h-异吲哚衍生物及其制备方法和中间体 |
JP2022532178A (ja) * | 2019-05-10 | 2022-07-13 | 上海海雁医薬科技有限公司 | 置換フェニルプロペニルピリジン誘導体、その調製方法及びその医学的使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0008864A1 (en) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
-
1995
- 1995-12-27 GB GBGB9526558.3A patent/GB9526558D0/en active Pending
-
1996
- 1996-12-13 CN CN96199282A patent/CN1066732C/zh not_active Expired - Fee Related
- 1996-12-13 PT PT96941882T patent/PT874845E/pt unknown
- 1996-12-13 EP EP96941882A patent/EP0874845B1/en not_active Expired - Lifetime
- 1996-12-13 DE DE69619702T patent/DE69619702T2/de not_active Expired - Fee Related
- 1996-12-13 DK DK96941882T patent/DK0874845T3/da active
- 1996-12-13 HU HU9901038A patent/HUP9901038A3/hu unknown
- 1996-12-13 WO PCT/JP1996/003666 patent/WO1997024355A1/en not_active Application Discontinuation
- 1996-12-13 IL IL12467396A patent/IL124673A/en not_active IP Right Cessation
- 1996-12-13 JP JP9524170A patent/JP2000502699A/ja active Pending
- 1996-12-13 EA EA199800599A patent/EA001324B1/ru not_active IP Right Cessation
- 1996-12-13 US US09/091,361 patent/US6117875A/en not_active Expired - Fee Related
- 1996-12-13 AT AT96941882T patent/ATE214067T1/de not_active IP Right Cessation
- 1996-12-13 ES ES96941882T patent/ES2170286T3/es not_active Expired - Lifetime
- 1996-12-13 KR KR1019980704348A patent/KR19990072053A/ko not_active Application Discontinuation
- 1996-12-13 CA CA002241690A patent/CA2241690A1/en not_active Abandoned
- 1996-12-13 AU AU11112/97A patent/AU720301B2/en not_active Ceased
-
1998
- 1998-06-24 MX MX9805129A patent/MX9805129A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP9901038A2 (hu) | 1999-07-28 |
DE69619702D1 (de) | 2002-04-11 |
JP2000502699A (ja) | 2000-03-07 |
IL124673A0 (en) | 1998-12-06 |
CN1205702A (zh) | 1999-01-20 |
ES2170286T3 (es) | 2002-08-01 |
CA2241690A1 (en) | 1997-07-10 |
CN1066732C (zh) | 2001-06-06 |
EP0874845A1 (en) | 1998-11-04 |
MX9805129A (es) | 1998-10-31 |
WO1997024355A1 (en) | 1997-07-10 |
AU720301B2 (en) | 2000-05-25 |
IL124673A (en) | 2002-07-25 |
KR19990072053A (ko) | 1999-09-27 |
DK0874845T3 (da) | 2002-07-01 |
EP0874845B1 (en) | 2002-03-06 |
US6117875A (en) | 2000-09-12 |
DE69619702T2 (de) | 2002-08-14 |
HUP9901038A3 (en) | 2000-04-28 |
GB9526558D0 (en) | 1996-02-28 |
AU1111297A (en) | 1997-07-28 |
EA199800599A1 (ru) | 1998-12-24 |
ATE214067T1 (de) | 2002-03-15 |
EA001324B1 (ru) | 2001-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT874845E (pt) | Derivados de pirido¬2,3-b|pirazina | |
AU4954097A (en) | 2-pyrimidineamine derivatives and processes for their preparation | |
AU7453498A (en) | Sulfonamide derivatives, their production and use | |
DE69425431T2 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
TW349098B (en) | Naphthalene derivatives, process for the preparation thereof, and intermediates therefor | |
DE60026514D1 (de) | Neue prolinverbindungen als mikrobizide mittel | |
AU1200695A (en) | 4,5-diaryloxazole derivatives | |
CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
EP1140900A4 (en) | PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS | |
MX9703634A (es) | Derivados de dibencimidazol antibacterianos. | |
AU1556997A (en) | Chinoline and benzimidazole derivatives as bradykinin agonists | |
DK0960111T3 (da) | Morphinderivat med analgesisk aktivitet | |
NZ332310A (en) | Optionally condensed pyrimidine substituted hexahydro-pyrido[4,3-b]indole derivatives and medicaments | |
CA2195031A1 (en) | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | |
EP1110960A4 (en) | AGENTS INDUCING APOPTOSIS | |
DE69613385T2 (de) | Cephemverbindungen | |
TW333525B (en) | New perhydroisoindole derivatives, their preparation and the pharmaceutical compositions which contain them the invention relates to perhydroisoindole derivatives of general formula (I), and their salts when they exist advantageously as neurokinin A antagonists. | |
DE60002292T2 (de) | (3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl)-3-(1h-indol-3-yl)-alkylamine |